Silver Oak Securities’s West Pharmaceutical WST Stock Holding History

Silver Oak Securities’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572K	Buy	+1,593	New	+$487K	0.03%	432
2023 Q4	–	Sell	-55	Closed	-$20.6K	–	545
2023 Q3	$20.6K	Sell	55 -995	-95%	-$385K	﹤0.01%	401
2023 Q2	$402K	Sell	1,050 -268	-20%	-$95.7K	0.06%	274
2023 Q1	$458K	Buy	+1,318	New	+$385K	0.08%	205
2022 Q4	–	Sell	-55	Closed	-$20.6K	–	493
2022 Q3	$20.6K	Sell	55 -606	-92%	-$185K	﹤0.01%	401
2022 Q2	$207K	Sell	661 -39	-6%	-$12.7K	0.05%	256
2022 Q1	$290K	Buy	+700	New	+$274K	0.06%	240

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Silver Oak Securities's WST Position: Q2 2026 in Review

Silver Oak Securities opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,593 shares worth $572K. The stake represents 0.03% of the portfolio and ranks #432 among its holdings. This is a return to the name: Silver Oak Securities previously reported a position in WST as recently as Q3 2023.

Silver Oak Securities first reported a position in WST in Q1 2022 and has held it in 7 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Silver Oak Securities held 1,593 shares of West Pharmaceutical worth $572K as of Q2 2026.
West Pharmaceutical was a new Silver Oak Securities position in Q2 2026.
West Pharmaceutical made up 0.03% of Silver Oak Securities's portfolio in Q2 2026, its #432 holding.
Silver Oak Securities first reported a position in West Pharmaceutical in Q1 2022 and has held it in 7 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.